Clinical trials: Eye Enucleation
Retinoblastoma
Intra-arterial Chemotherapy With Melphalan for the Treatment of Retinoblastoma (RTB) in Advanced Intraocular Stage
For selected cases with advanced Retinoblastoma (RTB) intraocular involvement(stage V of the Reese-Ellsworth classification) in which enucleation would usually be the standard therapeutic approach, in this project the…
- Trial name
- NCT01393769
- Testing
- Melphalan
- Where
- Spain
- Volunteers
- 5 people
- Sponsor
- Hospital Sant Joan de Deu
Retinoblastoma
Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma
The purpose of this study is to determine the effect of 3 cycles of chemotherapy(CEV) in the treatment of Stage I enucleated retinoblastoma.
- Trial name
- NCT05080010
- Testing
- 3 cycles chemotherapy
- Where
- China
- Volunteers
- 500 people
- Sponsor
- Sun Yat-sen University
Retinoblastoma
Superselective Intra-arterial Chemotherapy Treatment for Retinoblastoma- 5 Year Results From Turkey
Retrospective review of 5-year long term outcomes of superselective intra-arterial chemotherapy treatment in retinoblastoma in a single institute.
- Trial name
- NCT03935074
- Testing
- intra-arterial administration of melphalan
- Where
- Turkey (Türkiye)
- Volunteers
- 30 people
- Sponsor
- Istanbul University - Cerrahpasa
Retinoblastoma, Retinal Neoplasm
Study of Treatment for Patients With Cancer of the Eye -Retinoblastoma
Retinoblastoma is a childhood cancer which affects the retina of the eye. The retina is the light sensitive layer of tissue that lines the back of the eyeball; sends visual messages through the optic nerve to the brain.
- Trial name
- NCT00186888
- Testing
- Enucleation, Vincristine, Carboplatin, Focal Therapies
- Where
- United States
- Volunteers
- 107 people
- Sponsor
- St. Jude Children's Research Hospital
Enucleated; Eye
Digital Imaging Assessment of Ocular Prosthesis Motility
This study will evaluate the degree of translational movement loss from orbital implant to ocular prosthesis. This will be measured using two software applications - Image J as well as the mediGrid smartphone app in measuring…
- Trial name
- OCUPEYE (NCT03819621)
- Testing
- IRISS Medical Technologies mediGrid app
- Where
- United Kingdom
- Volunteers
- 57 people
- Sponsor
- Moorfields Eye Hospital NHS Foundation Trust